These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 399521)

  • 21. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
    LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
    Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective monitoring and modulation of immune reactivity in allograft recipients.
    Thomas F; Lee HM; Thomas J; Mendez-Picon G
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():20-6. PubMed ID: 801063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement.
    Dormont J; Kreis H; Leski M; Bach JF; Crosnier J
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):382-9. PubMed ID: 4627946
    [No Abstract]   [Full Text] [Related]  

  • 25. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective study of the clinical relevance of the current serum antiglobulin-augmented T cell crossmatch in renal transplant recipients.
    Johnson A; Hallman J; Alijani MR; Melhorn N; Lim LY; Jenson AB; Helfrich GB
    Transplant Proc; 1987 Feb; 19(1 Pt 1):792-3. PubMed ID: 3274875
    [No Abstract]   [Full Text] [Related]  

  • 27. [Analysis of T-cell subpopulations and expression patterns of lymphocytic activation markers in patients in the early phase following kidney transplantation using laser flow cytometry].
    Kaden J; Falck P; Eichler C; Strobelt V; May G; Volk HD
    Z Urol Nephrol; 1989 Oct; 82(10):531-9. PubMed ID: 2575311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of kidney transplantation in Poland.
    Rowiński W
    Pol Med J; 1971; 10(2):417-24. PubMed ID: 4934231
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation.
    Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):247-50. PubMed ID: 8438288
    [No Abstract]   [Full Text] [Related]  

  • 30. Analyses of histocompatibility in cadaver renal transplantation.
    Morris PJ
    Transplant Proc; 1971 Jun; 3(2):1030-5. PubMed ID: 4944045
    [No Abstract]   [Full Text] [Related]  

  • 31. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody.
    Halloran PF; Schlaut J; Solez K; Srinivasa NS
    Transplantation; 1992 Mar; 53(3):550-5. PubMed ID: 1549846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased reliance on cadaver grafts for renal transplantation:considerations for optimum effectiveness.
    Salvatierra O
    Transplant Proc; 1976 Jun; 8(2 Suppl 1):153-7. PubMed ID: 781937
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of dithiothreitol on a variety of evolutive patterns of anti-T and -B lymphocyte antibodies in renal transplant candidates.
    García de Masdevall MD; Arrieta A; Riñón M; Altés C; Arranz C
    Transplant Proc; 1992 Dec; 24(6):2505-7. PubMed ID: 1465847
    [No Abstract]   [Full Text] [Related]  

  • 34. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A study of cellular immune response in HL-A identical renal transplant recipients.
    Turnipseed WD; Folger MR; Cerilli J
    Rev Surg; 1973; 30(5):372-4. PubMed ID: 4583630
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of lymphocytotoxic antibodies on the outcome of kidney transplantation].
    Drannik GN; Driianskaia VE; Montag TS
    Urol Nefrol (Mosk); 1990; (1):28-31. PubMed ID: 2336753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. T cell subset analysis and immune monitoring of kidney transplant recipients experiencing reversal or nonreversal of steroid-resistant rejection by plasma leukapheresis.
    Pennline KJ; Edwards MG; White S; Gelfand M; Helfrich GB
    Transplant Proc; 1984 Dec; 16(6):1550-4. PubMed ID: 6390862
    [No Abstract]   [Full Text] [Related]  

  • 38. [Serologic studies in patients with early transplant failure].
    Groth J; Knijnenburg C; Kaden J; Strobelt V; May G
    Z Urol Nephrol; 1986 Jul; 79(7):405-9. PubMed ID: 3532621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic significance of antilymphocyte antibodies in a perivital kidney allograft].
    Savchenko NE; Levin VI; Buglova SE; Chashinskaia TI
    Urol Nefrol (Mosk); 1984; (4):3-6. PubMed ID: 6382734
    [No Abstract]   [Full Text] [Related]  

  • 40. Cadaveric kidney transplantation in patients with lymphocytotoxic autoantibodies.
    Emonds MP; Dendievel J; Roels L; Waer M; Vanrenterghem Y; Vermylen C
    Transplant Proc; 1992 Dec; 24(6):2502-3. PubMed ID: 1465845
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.